Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google Scholar citation report
Citations : 1556

Journal of Pain & Relief received 1556 citations as per Google Scholar report

Journal of Pain & Relief peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Cosmos IF
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Advances in photobiomodulation therapy - a new paradigm in pain management

4th International Conference on Pain Medicine

Richard K Williams

LightMD & Applied BioPhotonics, USA

Keynote: J Pain Relief

DOI: 10.4172/2167-0846-C1-016

Abstract
The advent of new generation medical-grade LED biophotonic devices for the clinical treatment of pain using photobiomodulation therapy (PBT) is discussed. Compared to present-day LED and laser phototherapies, the deviceâ??s advanced technology and intuitive user interface enables a physician or pain therapist unparalleled control of treatment conditions to maximize PBT efficacy including average power control of LED brightness and temperature, sequencing various LED wavelengths for controlling light penetration depth and mix, treatment duration to control total energy dose, and pulse frequency control for improved tissue specificity. The importance of treatment frequency in LightMD case studies and the possible photochemical and photobiological mechanisms for observed pulse frequency dependence on pain and nerve inflammation is considered. In addition to advances in photonic control, a new manufacturing technology for 3D bendable â??LightPadsâ? is described, each comprising an array of over 200 high-brightness LEDs housed in non-porous, aseptic, hypoallergenic polymeric pads, designed to bend and fit snugly to a personâ??s body contours to reduce optical refraction from epithelial tissue, maximize energy coupling, and enhance PBT efficacy. Compared to the small spot size of laser probes and LED wands, a set of six LightPads offers hands-free treatment of injured or painful tissue 300 times the area of conventional probes. The professional medical PBT device is FDA audited and approved in United States, Taiwan, Dubai, and the United Arab Emirates; CE and ISO-13485 medical safety rated, uses FDA-certified good manufacturing practices (GMP), and is IEC rated for photobiological safety (no glasses required). A sneak peek of a lower cost â??prosumerâ? (professional-consumer) device will also be provided
Biography

Richard is a serial entrepreneur, technologist, author, speaker, and prolific inventor. Currently he is CEO, President, and Chief Technology Officer (CTO) of Applied BioPhotonics Ltd., a Hong Kong based medical-device design specifier and GMP-certified manufacturing company, and is CEO of LightMD Inc., a Silicon Valley based seller of photobiomodulation therapy (PBT) devices. In 1999, he founded Advanced Analogic Technologies, and as CEO-CTO developed the first LED backlight dimming and LED camera flash for smartphones, followed by dynamic LED backlighting for major brand HDTVs.
 

Relevant Topics
Top